Suppr超能文献

木瓜叶提取物逆转 GBM 患者化疗诱导血小板减少症的病例研究。

A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient.

机构信息

University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Mayfield Clinic, Cincinnati, OH, USA.

出版信息

Integr Cancer Ther. 2022 Jan-Dec;21:15347354211068417. doi: 10.1177/15347354211068417.

Abstract

Chemotherapy-induced thrombocytopenia (CIT) is a critical condition in which platelet counts are abnormally reduced following the administration of chemotherapeutic compounds. CIT poses a treatment conundrum to clinicians given the increased risk of spontaneous bleeding, obstacles to surgical management of tumors, and exclusion from clinical trials. Treatment of CIT involves the removal of the offending agent combined with platelet infusion or thrombopoietin agonist treatment. However, due to the autoimmune and infection risks associated with infusions, this treatment is only reserved for patients with critically low platelet counts. One potential solution for patients in the mid to low platelet count range is leaf extract (CPLE). In this case, we report the novel use of CPLE as a method of bolstering platelet counts in a patient presenting with CIT. The patient was initiated on CPLE therapy consisting of 1 tablespoon twice daily with meals. Following CPLE treatment, the patient's platelet counts rebounded from less than 10,000/µL to 113,000/µL. This clinical vignette supports the use of CPLE in the clinical context of CIT when thrombopoietin agonists are not a viable option. The potential benefits of CPLE as a method for increasing platelet count deserve further exploration, especially as a treatment option for refractory patients or those ill-suited for other traditional thrombocytopenia therapies.

摘要

化疗诱导的血小板减少症 (CIT) 是一种严重的病症,在使用化疗化合物后血小板计数异常减少。CIT 给临床医生带来了治疗难题,因为这会增加自发性出血的风险、妨碍肿瘤的手术治疗,以及排除临床试验。CIT 的治疗包括去除致病药物,同时输注血小板或血小板生成素激动剂。然而,由于输注相关的自身免疫和感染风险,这种治疗仅保留给血小板计数极低的患者。对于血小板计数中等或较低的患者,一种潜在的解决方案是[草药名称]提取物 (CPLE)。在这种情况下,我们报告了 CPLE 作为一种提高 CIT 患者血小板计数的方法的新用途。该患者开始接受 CPLE 治疗,每天两次,每次 1 汤匙,随餐服用。在 CPLE 治疗后,患者的血小板计数从低于 10,000/µL 反弹至 113,000/µL。这一临床案例支持在没有血小板生成素激动剂的情况下,在 CIT 的临床情况下使用 CPLE。CPLE 作为增加血小板计数的方法的潜在益处值得进一步探索,特别是作为难治性患者或不适合其他传统血小板减少症治疗的患者的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/800a/8753228/f2cd264a6a99/10.1177_15347354211068417-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验